“ DEX infusion during the perioperative period inhibited release of epinephrine , norepinephrine, and cortisol; decreased blood glucose, interleukin (IL)-6, tumour necrosis factor-α, and C-reactive protein; and increased interleukin-10 in surgical patients.”